International Journal of Molecular Sciences (Jan 2022)

Adipose Stromal/Stem Cell-Derived Extracellular Vesicles: Potential Next-Generation Anti-Obesity Agents

  • Mariachiara Zuccarini,
  • Patricia Giuliani,
  • Valentina Di Liberto,
  • Monica Frinchi,
  • Francesco Caciagli,
  • Vanni Caruso,
  • Renata Ciccarelli,
  • Giuseppa Mudò,
  • Patrizia Di Iorio

DOI
https://doi.org/10.3390/ijms23031543
Journal volume & issue
Vol. 23, no. 3
p. 1543

Abstract

Read online

Over the last decade, several compounds have been identified for the treatment of obesity. However, due to the complexity of the disease, many pharmacological interventions have raised concerns about their efficacy and safety. Therefore, it is important to discover new factors involved in the induction/progression of obesity. Adipose stromal/stem cells (ASCs), which are mostly isolated from subcutaneous adipose tissue, are the primary cells contributing to the expansion of fat mass. Like other cells, ASCs release nanoparticles known as extracellular vesicles (EVs), which are being actively studied for their potential applications in a variety of diseases. Here, we focused on the importance of the con-tribution of ASC-derived EVs in the regulation of metabolic processes. In addition, we outlined the advantages/disadvantages of the use of EVs as potential next-generation anti-obesity agents.

Keywords